Inflammation and coronary heart disease: An overview

Cardiology in Review

Volumn 9, Issue 1, 2001, Pages 31-35

  Koenig, Wolfgang ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Coronary heart disease; Inflammation; Prediction; Therapeutic implications

Indexed keywords

ANTILIPEMIC AGENT; C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN;

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR INFLAMMATION; CARDIOVASCULAR RISK; CORRELATION FUNCTION; DISEASE MARKER; ENDOTHELIUM CELL; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; PATHOGENESIS; PREDICTION; REVIEW; RISK FACTOR;

EID: 0035187721     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045415-200101000-00007     Document Type: Review

References (24)

1. Lipids, risk factors, and ischaemic heart disease
2. Molecular bases of the acute coronary syndromes
3. Coronary plaque disruption
4. Stability and instability: Two faces of coronary atherosclerosis
5. Lipid lowering and plaque regression: New insights into prevention of plaque disruption and clinical events in coronary disease
6. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
7. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease
8. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
9. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992
10. Inflammation, pravastatin, and risk of coronary events after myocardial infarction in patients with average cholesterol levels
11. Prospective studies of C-reactive protein as a risk factor for cardiovascular disease
12. Acute coronary thrombosis - The role of plaque disruption and its initiation and prevention
13. Fibrinogen and cardiovascular risk
14. Compensatory enlargement of human atherosclerotic coronary arteries
15. Fibrinolytic and inflammatory markers for arterial occlusion: The evolving epidemiology of thrombosis and hemostasis
16. Elevation of C-reactive protein in "active" coronary artery disease
17. Inflammation in ischaemic heart disease
18. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study
19. Antiatherothrombotic properties of statins: Implications for cardiovascular event reduction
20. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
21. Hormone replacement therapy and increased plasma concentration of C-reactive protein
22. Effects of hormone replacement therapies on inflammatory and hemostatic markers in postmenopausal women
23. Effect of postmenopausal hormones on inflammation-sensitive proteins
24. Long-term effects of pravastatin on plasma concentration of C-reactive protein